Yahoo
    LSE - Delayed Quote USD

    Neurocrine Biosciences, Inc. (0K6R.L)

    162.01 -6.09 (-3.62%)
    At close: November 5 at 7:14:31 PM GMT
    Loading Chart for 0K6R.L
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Voyager Reports Third Quarter 2026 Financial and Operating Results

    Voyager Reports Third Quarter 2026 Financial and Operating Results
    GlobeNewswire 10h ago
    Neurocrine Biosciences Presents New Tardive Dyskinesia Survey Results Showing Fewer Work and School Disruptions with INGREZZA® (valbenazine) Capsules

    Neurocrine Biosciences Presents New Tardive Dyskinesia Survey Results Showing Fewer Work and School Disruptions with INGREZZA® (valbenazine) Capsules
    PR Newswire 17h ago
    Neurocrine Biosciences to Spotlight Its Scientific Journey and Growing Neuropsychiatry Pipeline at 2026 NEI Fall Congress

    Neurocrine Biosciences to Spotlight Its Scientific Journey and Growing Neuropsychiatry Pipeline at 2026 NEI Fall Congress
    PR Newswire 2d ago
    Is Neurocrine Biosciences (NBIX) A Bargain On Raised INGREZZA Guidance?

    Is Neurocrine Biosciences (NBIX) A Bargain On Raised INGREZZA Guidance?
    Simply Wall St. 2d ago
    Neurocrine Biosciences (NBIX) Starts Phase 2 Alzheimer’s Study And Expands Doctor Education

    Neurocrine Biosciences (NBIX) Starts Phase 2 Alzheimer’s Study And Expands Doctor Education
    Simply Wall St. 2d ago
    Neurocrine Biosciences (NBIX) Stock Looks Cheap After Its 55% Five Year Run

    Neurocrine Biosciences (NBIX) Stock Looks Cheap After Its 55% Five Year Run
    Simply Wall St. 2d ago
    This Biopharma Stock Hit a 6-Year High—and It Can Keep Climbing

    This Biopharma Stock Hit a 6-Year High—and It Can Keep Climbing
    Barrons.com 2d ago
    Neurocrine Biosciences Delivers Strong Q3 on Vykat Rebound, RBC Says

    Neurocrine Biosciences Delivers Strong Q3 on Vykat Rebound, RBC Says
    PREMIUM
    MT Newswires 2d ago
    NBIX Beats on Q3 Earnings & Sales, Raises '26 Ingrezza Sales View

    NBIX Beats on Q3 Earnings & Sales, Raises '26 Ingrezza Sales View
    Zacks 2d ago
    Neurocrine Biosciences, Inc. Q3 2026 Earnings Call Summary

    Neurocrine Biosciences, Inc. Q3 2026 Earnings Call Summary
    Moby 2d ago
    Neurocrine (NBIX) Q3 2026 Earnings Call Transcript

    Neurocrine (NBIX) Q3 2026 Earnings Call Transcript
    Motley Fool 3d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: